BCL2 and T-cell non-Hodgkin lymphoma: Another PROTAC of interest in hematology is DT2216, which targets Bcl-xL for degradation in T-cell lymphomas that greatly depend on the overexpressed proteins of the Bcl-2 family, such as Bcl-2, Bcl-xL, and Mcl-1 [82].